Authors
Loading...
Reduced hepatic TPO production may contribute to cirrhotic thrombocytopenia; leaves open its relative role versus splenic destruction for targeted therapies.
Key points are not available for this paper at this time.
Ishikawa et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: